Home
Inbox
Search
View Abstract
Content
Session(s)
P1019 Fevipiprant (QAW039) for Treatment of Patients with Uncontrolled Severe Asthma: Design of LUSTER1, a Phase III One-Year Exacerbation Study
Download
Send by Mail
View Handout
Home
Inbox
Search